United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 27, 2007
Hercules Incorporated
(Exact name of registrant as specified in its charter)
Delaware | 001-00496 | 51-0023450 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification Number) |
Hercules Plaza
1313 North Market Street
Wilmington, Delaware 19894-0001
(Address of principal executive offices) (Zip Code)
(302) 594-5000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On August 27, 2007, Hercules Incorporated completed the purchase of the specialty surfactants business of Dexter Chemical L.L.C.
A news release regarding this transaction is furnished as an exhibit hereto and incorporated by reference herein.
- 2 -
EXHIBIT INDEX
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. 99.1 News Release of Hercules Incorporated dated August 28, 2007.
- 3 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| August 28, 2007 | By: | HERCULES INCORPORATED |
| /s/ Allen A. Spizzo | ||
| Allen A. Spizzo | ||
| Vice President and Chief Financial Officer |
- 4 -